Article Versions Notes

Hwang SY, Woo HY, Heo J, Kim HJ, Park YJ, Yi KY, Lee YR, Park SY, Chung WJ, Jang BK, et al. Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma. Cancers. 2024; 16(4):838. https://doi.org/10.3390/cancers16040838

Hwang, Sang Youn, Hyun Young Woo, Jeong Heo, Hyung Jun Kim, Young Joo Park, Ki Youn Yi, Yu Rim Lee, Soo Young Park, Woo Jin Chung, Byoung Kuk Jang, and et al. 2024. "Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma" Cancers 16, no. 4: 838. https://doi.org/10.3390/cancers16040838

Hwang, S. Y., Woo, H. Y., Heo, J., Kim, H. J., Park, Y. J., Yi, K. Y., Lee, Y. R., Park, S. Y., Chung, W. J., Jang, B. K., & Tak, W. Y. (2024). Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma. Cancers, 16(4), 838. https://doi.org/10.3390/cancers16040838